# Aktis Oncology, Inc. (AKTS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AKTS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 6.61M | $ -42.47M | $ -47.95M | $ 11.24M | $ 484.84M |
| 2025 | $ 1.91M | $ -15.50M | $ -19.86M | $ 11.55M | $ -146.15M |
| 2024 | $ 980.7K | $ -12.67M | $ -15.80M | $ 12.01M | $ -87.80M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.02 |
| Liabilities / Eq | 0.15 |
| Current Ratio | 16.33 |

## Other views

- [Metrics](https://sponda.capital/en/AKTS.md)
- [Charts](https://sponda.capital/en/AKTS/charts.md)
- [Compare](https://sponda.capital/en/AKTS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.